Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00724594

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

Safety of N-acetylcysteine in Maternal Chorioamnionitis

Sponsor: Medical University of South Carolina

Conditions Brain Injury Chorioamnionitis

Updated 10 times since 2017 Last updated: Mar 17, 2021 Started: Aug 31, 2008 Primary completion: Jul 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Brain Injury and Chorioamnionitis, this trial is completed. The trial is conducted by Medical University of South Carolina and has accumulated 10 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1_PHASE2
May 2021 — Dec 2022 [monthly]

Completed PHASE1_PHASE2

▶ Show 5 earlier versions

Jan 2021 — May 2021 [monthly]

Completed PHASE1_PHASE2
Dec 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Dec 2018 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
National Institute of Neurological Disorders and Stroke (NINDS)

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States